
New York Declares Total War on Prolific Rat Population
Faced with an overwhelming and ever-growing problem, officials have moved beyond gassing burrows to suffocate rodents and are now using high-tech mapping tools to try and sterilize the population.
Alongside targeted interventions, officials are mounting an effort to educate the public about the need to avoid leaving behind food waste that feeds and sustains the rat population.
Caroline Bragdon, director of neighborhood interventions for Pest Control Services within New York City's Department of Health, told AFP that the lack of food "stresses" rats and other vermin.
"Perhaps this forces them to go further in search of food, but perhaps they simply have fewer offspring," she said.
"That's usually what we're seeing. Fewer rats over time. Less breeding leads to less rat activity," Bragdon added.
The city is testing out an arsenal of different tools in the Harlem neighborhood, aiming to find new products and methods to tackle the rats.
For large, densely populated cities like New York -- with its 8.5 million inhabitants -- food sources for the rodents are bountiful, whether it's on sidewalks, in overflowing trash bins, or in parks.
"Lately, I haven't felt that I have to run in between the mounds of trash to run away from rats because they have those new (sealed trash) containers," said Harlem resident Karen Del Aguila, 50.
Rats, which survive on practically the same diet as humans, can flourish even on items discarded as trash -- like soda cans thrown into recycling bins, or crumbs given to pigeons, warned Bragdon.
A rat needs one ounce (28 grams) of food per day to sustain itself, and it can have up to 12 offspring per litter.
During its short life of less than a year, it can have between five and seven litters.
The best way to counter the scourge of rats is to "remove their food source... So make it harder for them, then they're going to have to travel further to try and find something," said Alexa Albert, a supervisor for the city's pest control service.
- 'It can be done' -
She swiped her screen to show the street-level data logged on a rat tracker app used by those involved in the crusade against rodent infestation.
The city health department's 70 inspectors use the mobile app to detect, report and monitor rodent activity -- as well as plot abatement tactics.
Inspectors go door to door asking businesses and residents to clean buildings, stores, and sidewalks.
Authorities also now offer training on how to combat rats, taken by thousands of residents and building managers.
In October 2022, New York City vaunted a "trash revolution," aimed at installing sealed containers to allow the removal of black bags of organic waste from sidewalks after rats surged during the coronavirus pandemic.
Pre-pandemic, their population had been cut by as much as 90 percent in some areas.
"So we know it can be done," said Bragdon, who added that she hoped 2025 would be a "turnaround year."
Local resident Jessica Sanchez said she had observed much fewer rats in her neighborhood.
"Not a long time ago, when you went to put out the trash, five of them came out," she said.
"I was even afraid to put my son on the floor."
The rat warriors are seeking to learn the rodents' dietary habits throughout the year by using samples of different food types to identify what bait they are most likely to take.
In 2024, complaints about rat activity dropped 25 percent compared to the year before, according to official data.
But so far, only Manhattan's Chinatown has managed to bring the rat population under control.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Al Arabiya
3 hours ago
- Al Arabiya
Whoop refuses to disable blood pressure tool despite FDA warning
Whoop Inc., the maker of screen-less fitness bands, said it will not disable its blood-pressure tracking tool despite a request from the US Food and Drug Administration. The FDA last month sent a warning letter to Whoop stating that the company's Blood Pressure Insights feature, or BPI, which both measures blood pressure and provides related feedback, means that the Whoop is operating as a medical device. The new Whoop MG — short for medical grade — doesn't have such certification for blood pressure tracking despite intending to 'help with the diagnosis, cure or treatment of a disease,' according to the government agency. The band launched in May with the feature as a central addition. Whoop pushed back on the FDA's warning in a letter to the agency dated Aug. 4. 'We believe it is not within the FDA's authority to regulate the product. We therefore do not intend to remove the app,' the company wrote. 'We will continue to offer the wellness feature to consumers.' It added in a statement that it has 'requested a meeting with the FDA and hopes to have a constructive dialogue with agency officials.' On Thursday an FDA spokesperson said the agency 'has not authorized BPI for any use, including for the measurement or estimation of a user's blood pressure,' adding that 'patient safety is the FDA's highest priority.' FDA Versus Tech The FDA has clashed periodically over the last dozen years with technology companies whose devices the agency believes need regulation because they constitute medical advice. Still, Whoop's defiant reaction is rare. While regulators have struggled to define exactly when the line from wellness to medical advice is crossed, tech firms have often taken offending products off the market and sought FDA clearance or tweaked their product to comply. Meanwhile, consumer hardware makers have been adding more sophisticated health tracking tools to their fitness bands and smartwatches, blurring the lines between a wearable gadget and medical device. While the FDA can impose injunctions and fines on companies that fail to comply with violations raised in warning letters, it's rare that it follows through. The agency initially told Whoop that it should take 'prompt action' to address any violations or face potential regulatory action, including seizure, injunction and civil monetary penalties. The FDA also told Whoop it could go through the normal device approval process, something that Whoop doesn't want to do given the long amount of time that could take. Whoop said in its response that the feature is labeled for wellness purposes, not for diagnosing or treating medical conditions like hypertension. Whoop also said that repeated disclaimers are provided during the sign-up process. It characterized the issue as a 'misinterpretation' by the FDA, saying the agency views blood pressure estimation as a medical tool. The 'FDA's assertions fail to account for the substantial and growing body of scientific evidence supporting non-medical uses of blood pressure as well as the actual use of blood pressure information by the feature,' the company said in its response, which was provided to Bloomberg News. The Blood Pressure Insights feature lets users get a daily estimate of their blood pressure range so they can better understand the impact on overall health and athletic performance. The tool is available only to subscribers of the $359-a-year Whoop Life plan. The feature requires an initial calibration with a standard blood pressure cuff. Whoop Chief Executive Officer Will Ahmed previously called the FDA's letter 'misguided' on social media. The FDA said the product does not fall under the general wellness device policy because blood pressure it is not a low-risk use case. 'An erroneously low or high blood pressure reading can have significant consequences for the user,' it said in its July letter to the fitness startup. During an interview with Bloomberg TV on Thursday, Ahmed said he believes the company will be on the 'right side of history' and fighting for Americans' access to health data is the 'right thing to do.' 'Ultimately, innovation needs to be built to thrive in the United States,' he said. 'We're one of the first wearables that can measure blood pressure accurately on the wrist. That's a big deal. We want to make sure that there are policies that are consistent here in the US that really allow companies to innovate and to operate.' Other companies such as Garmin Ltd. offer FDA-cleared blood pressure reading tools. It's a feature also available on smartwatches from Samsung Electronics Co. Health and Human Services Secretary Robert F. Kennedy Jr. has promoted the use of wearable fitness devices. In an appearance before Congress in June, he said his vision is for every American to be using a wearable device within four years. Whoop CEO Ahmed was pictured meeting with Kennedy and other health tech companies in May.


Al Arabiya
a day ago
- Al Arabiya
One in four US adults with diabetes used GLP-1 injections in 2024: CDC
More than one in four US adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, the US Centers for Disease Control and Prevention said on Thursday. The wildly popular and effective GLP-1 drugs Mounjaro from Eli Lilly and Ozempic from Novo Nordisk are approved in the United States for treating type 2 diabetes. They are sold as Zepbound and Wegovy, respectively, for weight loss and are being tested for other conditions. Use of the injectable drugs was highest among adults with diabetes aged 50–64 at 33.3 percent, reflecting the more significant disease burden in this group, the report said. A quarter or 25.3 percent of adults with diabetes aged 18 to 34 reported using a GLP-1 drug, while the adoption rate was 20.8 percent among those 65 and older. The data are from a nationally representative annual survey of US adults aged 18 and older that was conducted in person and with follow-up by phone in 2024. In 2024, for the first time, participants in the annual survey who had diabetes were asked if they were using the Lilly or Novo blockbusters or other GLP-1 drugs to lower blood sugar or lose weight. The drugs mimic the activity of a hormone that regulates blood sugar levels, slows digestion and helps people feel full for longer. Drugmakers Lilly and Novo have faced criticism about the cost of the treatments, which carry a list price of about $1,000 for a month's supply. Roughly 31 percent of survey participants who reported using insulin also reported using GLP-1 drugs, as did about 28 percent of patients who were using oral drugs to control their blood sugar, according to the report, indicating that these treatments are being integrated into combination regimens. Hispanic adults with diabetes had the highest rate of GLP-1 use, at 31.3 percent, followed by Black non-Hispanic and White non-Hispanic adults, at 26.5 percent and 26.2 percent, respectively, the survey found. Only 12.1 percent of Asian non-Hispanic adults with diabetes used the drugs, which may reflect disparities in access or adoption of the therapies.

Al Arabiya
3 days ago
- Al Arabiya
US CDC tightens security after gunman attacks Atlanta headquarters
The US CDC has tightened security following an attack Friday on its Atlanta headquarters that left a police officer and the gunman dead, including having most employees work from home this week and removing vehicle decals showing where they work. The union representing workers at the Centers for Disease Control and Prevention said the violence 'compounds months of mistreatment, neglect, and vilification that CDC staff have endured,' citing reports that the gunman blamed the COVID-19 vaccine for making him depressed and suicidal. Since being named Health and Human Services Secretary earlier this year, Robert F. Kennedy Jr. has targeted vaccine policy, and in May withdrew a federal recommendation for COVID shots for pregnant women and healthy children. Kennedy toured the CDC site on Monday, where agency security pointed out shattered windows across multiple buildings, including the main guard booth, HHS said in a statement. He also visited the DeKalb County Police Department and met privately with the widow of Officer David Rose, who gave his life in the line of duty. 'No one should face violence while working to protect the health of others,' Kennedy Jr. said in a post on X on Saturday. HHS said it continues to support CDC personnel and additional safety and security measures are being put in place ahead of their return to the office. A source briefed on the matter told Reuters that 189 rounds of gunfire had hit the CDC buildings during the attack, 85 windows were broken and over 100 doors destroyed, among other damage. Both local and federal law enforcement are 'conducting intensive monitoring of all potential threats to CDC and its staff,' the agency's acting Chief Operating Officer Christa Capozzola said in an email to staff over the weekend that was seen by Reuters. She said work was under way to clean up and repair extensive damage to the CDC's campus by the shooter who, according to the investigation so far, acted alone. An 'all-staff' meeting on Tuesday will become a virtual-only event, CDC Director Susan Monarez said in a separate email seen by Reuters. She said teams were working to determine 'our workplace posture' moving forward. The agency's safety division asked employees to remove CDC-identifying decals from their vehicles, an email seen by Reuters showed. The Atlanta Police Department referred calls to the Georgia Bureau of Investigation, which did not have an immediate comment.